DuPont Q1 loss of $548 million on $768 million charge; adjusted EPS rises 30%
DuPont reported first quarter 2025 net sales of $3.1 billion, up 5%, and adjusted EPS of $1.03, up 30% from a year earlier. A $768 million non-cash goodwill impairment tied to its Aramids business drove a GAAP loss from continuing operations of $548 million, or $(1.33) per share. The company kept its full year 2025 guidance unchanged and estimates tariffs at about $60 million, which that guidance does not include.
Key points
- Net sales rose 5% to $3.1 billion, with organic sales up 6%.
- GAAP loss from continuing operations was $548 million, or $(1.33) per share, including a $768 million non-cash goodwill impairment charge.
- Adjusted EPS rose 30% to $1.03 from $0.79; operating EBITDA rose 16% to $788 million.
- Full year 2025 guidance was maintained; tariffs are estimated at about $60 million, or about $0.10 per share, and are excluded from guidance.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 02, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.